The Ledger

1.09 billion dollars: that is the operating income Oscar Health already banked in just the first half of 2026, more than its entire newly raised full-year guidance implies it will keep, meaning the insurer’s own numbers point to a swing back to a loss in the second half. Oscar Health reported second quarter 2026 revenue of 4.88 billion dollars, up 71 percent from 2.86 billion dollars a year earlier, with net income of 361.8 million dollars, or 1.10 dollars a diluted share, reversing a 228.4 million dollar net loss in the second quarter of 2025; the medical loss ratio improved to 79.2 percent from 91.1 percent, and effectuated individual and small group membership reached 2,963,002. The company raised its full year 2026 earnings from operations guidance to a range of 500 million to 700 million dollars, up from 250 million to 450 million dollars, and tightened its medical loss ratio guidance to 81.5 to 82.5 percent; but Oscar’s own first half operating income already totals roughly 1.093 billion dollars, 704.1 million dollars in the first quarter plus 388.6 million dollars in the second, meaning the raised full year guidance implies an operating loss of between roughly 393 million and 593 million dollars in the second half. Confidence: High on the reported and guidance figures, which come directly from the company’s own release. Confidence: Medium on the implied second-half loss, since that figure is this run’s arithmetic from Oscar’s stated numbers rather than a figure the company states outright. Source: Oscar Health Announces Record Financial Results for First Half 2026 and Raises Full Year 2026 Outlook, Oscar Health investor relations.

632.6 million dollars: that is Privia Health’s second quarter revenue, up 21.4 percent, as the physician-enablement company raised guidance and more than tripled its profit. Privia Health, which helps independent physician practices convert to value-based care arrangements, reported second quarter 2026 revenue of 632.6 million dollars, net income of 9.0 million dollars, up 236.7 percent year over year, and adjusted EBITDA of 37.4 million dollars, up 29.1 percent; implemented providers grew to 5,644, up 10.1 percent, and value-based care attributed lives reached 1.647 million, up 19.2 percent, while practice collections totaled 970.0 million dollars. The company raised full year 2026 guidance to the high end of its prior range, 2.35 to 2.45 billion dollars in revenue and 145 to 155 million dollars in adjusted EBITDA. Confidence: High. The figures come directly from the company’s own release. Source: Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results, GlobeNewswire.

157,309 members: that is how many people were enrolled in Clover Health’s Medicare Advantage plans at quarter’s end, up 48 percent in a year, as the AI-driven insurer swung to a profit. Clover Health reported second quarter 2026 revenue of 743.2 million dollars, up 55.6 percent from 477.6 million dollars a year earlier, and net income of 28.0 million dollars, a 39 million dollar swing from a 10.6 million dollar net loss in the second quarter of 2025; its insurance benefits expense ratio improved to 87.6 percent from 88.4 percent. The company raised full year 2026 guidance to 2.92 to 3.00 billion dollars in revenue and 20 to 35 million dollars in GAAP net income, crediting what it calls a wide network, full risk Medicare Advantage model built around its own Counterpart Health software. Confidence: High. The figures come directly from the company’s own release. Source: Clover Health Reports Second Quarter 2026 Results, GlobeNewswire.

4.55 billion dollars: that is how much less Medicare would pay for drugs administered in hospital outpatient departments next year under a newly proposed rule, most of it from a single change to how the program prices drugs bought through the 340B discount program. The Centers for Medicare and Medicaid Services proposed its calendar year 2027 Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center rule July 2, 2026, published in the Federal Register July 7; the rule would pay 340B-acquired drugs at average sales price minus 33.4 percent starting January 1, 2027, versus the standard average sales price plus 6 percent for non-340B drugs, a change CMS projects will cut Original Medicare drug payments by 4.55 billion dollars and beneficiary drug cost-sharing by 1.15 billion dollars in the first year; hospitals would bill the change using modifier JG for discounted 340B drugs, modifier TB for exempt 340B drugs, and a newly proposed modifier XX for non-340B drugs, the first time claims will flag 340B-versus-non-340B drug administration at the line-item level. The same rule proposes removing 637 more procedures from Medicare’s inpatient-only list for 2027, the second phase of a wind-down that removed 285 procedures in 2026, and extending site-neutral, physician-fee-schedule-equivalent payment to non-contrast imaging performed in off-campus hospital outpatient departments, which CMS estimates will cut Medicare Part B spending by about 260 million dollars in the first year, 190 million of it in program savings and 70 million in reduced beneficiary cost-sharing; the proposed conversion factor is 102.004 dollars, up from 91.415 dollars this year. Comments close August 31, 2026. Confidence: High. The dollar and date figures come directly from the rule’s own regulatory text and CMS’s fact sheet, though CMS’s fact sheet states 638 procedures leaving the inpatient-only list while the rule’s own regulatory text says 637, a discrepancy between the agency’s two primary documents this run could not resolve. Sources: Calendar Year 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center Payment System Proposed Rule, Centers for Medicare and Medicaid Services, Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; CY 2027 Payment Policies, Federal Register.

1 million dollars: that is what a hospital company’s own founder personally loaned a struggling Illinois hospital this week so employees could be paid, the fourth payroll disruption there since January. Gateway Regional Medical Center, a 343-bed hospital in Granite City, Illinois owned by Los Angeles-based American Healthcare Systems, missed payroll again in early August 2026; founder Mike Sarian and his wife Evelina personally loaned the hospital 1 million dollars so hundreds of employees could be paid by August 3, with hospital administration citing a cash flow issue and pointing to an ongoing transition to a new billing and revenue cycle system. State Senator Erica Harriss said the Illinois Department of Public Health is actively monitoring the situation; Sarian separately faces civil lawsuits in Florida and Nevada alleging he diverted hospital funds at other facilities, allegations he denies. Confidence: Medium. The payroll and loan details are corroborated by local reporting citing hospital communications and a state senator’s public statement, but this run could not independently retrieve a hospital-issued financial statement. Sources: Cash flow issue forced Metro East medical center employees to be delayed pay, First Alert 4/KMOV, corroborated by Becker’s Hospital Review.

40 urgent care clinics: that is how many a hospital giant just absorbed into its own referral network in one deal, split three ways among its own regional hospital brands. HCA Healthcare closed its acquisition of Texas MedClinic in early August 2026, taking the 40-location urgent care chain, founded in San Antonio in 1982 and owned since 2022 by Community Care Partners, and dividing it among three HCA affiliates: Methodist Healthcare took 18 San Antonio-area clinics, St. David’s HealthCare took 14 Austin-area clinics, and HCA Houston Healthcare took the remaining 8; all 40 were rebranded under HCA’s CareNow urgent care division, which now runs more than 430 clinics nationwide, over 190 of them in Texas. Financial terms were not disclosed; HCA vice president of strategic growth Tyler Laymon said the deal is meant to build “new referral streams into HCA’s hospitals and specialty services,” part of a broader pattern of hospital systems buying urgent care chains to capture patients before they reach a competitor’s emergency room. FRONTIER SCAN. Confidence: Medium. The acquisition and its structure are reported directly by trade press citing company statements; this run could not independently retrieve an HCA press release or SEC filing describing the deal. Sources: HCA Healthcare acquires 40 Texas urgent care centers, Healthcare Dive, corroborated by Becker’s Hospital Review.

THE DEAL SHEET

Target	Acquirer/Investor	Vertical	Value	Source
Texas MedClinic (40 urgent care centers, San Antonio and Austin)	HCA Healthcare, via Methodist Healthcare, St. David’s HealthCare and HCA Houston Healthcare	Urgent care, hospital vertical integration	Undisclosed; closed early August 2026	HCA Healthcare acquires 40 Texas urgent care centers, Healthcare Dive
Cylinder Health, Inc.	Hinge Health, Inc.	Digital health, virtual gastrointestinal care	$105 million cash; signed August 4, 2026, expected to close Q3 2026	Hinge Health to acquire Cylinder Health, expanding into gastrointestinal care, Hinge Health investor relations
PANTHERx Rare	Warburg Pincus-led investor group	Specialty pharmacy	More than $7 billion including debt; announced July 13, 2026, Massachusetts Health Policy Commission material change notice filed August 3, 2026	Warburg Pincus-Led Investor Group Agrees to Acquire Controlling Interest in PANTHERx Rare, PR Newswire
Crossroads Medical Pavilion (White House, Tennessee medical office building)	Onicx Healthcare Real Estate	Medical office building real estate	$5.34 million acquisition financing arranged; August 4, 2026	Cushman & Wakefield Arranges Acquisition Financing for Nashville Medical Office Property, Connect CRE